Additionally, GREM1 contributes to T cell exhaustion by upregulating immune checkpoints like CTLA-4 and PD-1 and overactivating key signaling pathways, thereby impairing antitumor immunity and accelerating tumor progression (33, 34). Here, GREM1 is linked to neoplasm.